HEALTH: LUNG CANCER - SYMPTOMS & TREATMENT Bronchitis>>
What is Lung Cancer?
Lung cancer is cancer that begins in the lungs, the two organs found in the chest that help you breathe.
The lungs are made up of areas called lobes. The right lung has three lobes; the left lung has two, so there's room for the heart. When you breathe, air goes through your nose, down your windpipe (trachea), and into the lungs where it spreads through tubes called bronchi. Most lung cancer begins in the cells that line these tubes.
Lung cancer affects more than 200,000 Americans each year. Although cigarette smoking is the main cause, anyone can develop lung cancer. Lung cancer is always treatable, no matter the size, location, or if the cancer has spread.
The lung absorbs oxygen from the air and bring the oxygen into the bloodstream for delivery to the rest of the body. As the body’s cells use oxygen, they release carbon dioxide. The bloodstream carries carbon dioxide back to the lungs, and the carbon dioxide leaves the body when people exhale. The lung contains many different types of cells. Most cells in the lung are epithelial cells. Epithelial cells line the airways and produce mucus, which lubricates and protects the lung. The lung also contains nerve cells, hormone-producing cells, blood cells, and structural or supporting cells.
There are two major types of lung cancer: non-small cell and small cell. Non-small cell lung cancer (NSCLC) arises from epithelial cells and is the most common type. Small cell lung cancer begins in the nerve cells or hormone-producing cells of the lung. The term “small cell” refers to the size and shape of the cancer cells as seen under a microscope. It is important for doctors to distinguish NSCLC from small cell lung cancer because the two types of cancer are usually treated in different ways.
Lung cancer begins when cells in the lung grow out of control and form a lump (also called a tumor, mass, lesion, or nodule). A tumor can be benign (noncancerous) or malignant (cancerous). A cancerous tumor is a collection of a large number of cancer cells that have the ability to spread to other parts of the body. A lung tumor can begin anywhere in the lung.
Once a cancerous lung tumor begins to grow, it may or may not shed cancer cells. These cells can be carried away in blood or float away in the natural fluid, called lymph, which surrounds lung tissue. Lymph flows through tubes called lymphatic vessels that drain into collecting stations called lymph nodes, the tiny, bean-shaped organs that help fight infection. Lymph nodes are located in the lungs, the center of the chest, and elsewhere in the body. The natural flow of lymph out of the lungs is toward the center of the chest, which explains why lung cancer often spreads there. When a cancer cell leaves its site of origin and moves into a lymph node or to a far away part of the body through the bloodstream, it is called metastasis.
The location and size of the initial lung tumor, and whether it has spread to lymph nodes or more distant sites, determines the stage of lung cancer. The type of lung cancer (NSCLC versus small cell) and stage of the disease (discussed later in Staging) determine what type of treatment is needed.
_______________________________________________________________________________________________________
Also see: Emphysema Bronchitis Asthma Allergies Pneumonia Sinuses Common Cold Influenza/Flu Swine Flu
_______________________________________________________________________________________________________
Health: Risk Factors of Lung Cancer (Lungs)
Screening
A risk factor is anything that increases a person’s chance of developing cancer. Some risk factors can be controlled, such as smoking, and some cannot be controlled, such as age and family history. Although risk factors can influence the development of cancer, most do not directly cause cancer. Some people with several risk factors never develop cancer, while others with no known risk factors do. However, knowing your risk factors and communicating them to your doctor may help you make more informed lifestyle and health care choices.
The following factors may raise a person’s risk of developing lung cancer:
Tobacco. Most lung cancer occurs in people who smoke. Tobacco smoke damages cells in the lungs, causing the cells to grow abnormally. The risk that smoking will lead to cancer is higher for people who smoke heavily and/or for a long time. Regular exposure to smoke from someone else’s cigarettes, cigars, or pipes (called environmental or “secondhand” tobacco smoke) can increase a person’s risk of lung cancer even if that person does not smoke.
Asbestos. These are hair-like crystals found in many types of rock and are often used as fireproof insulation in buildings. When asbestos fibers are inhaled, they can irritate the lung. Many studies show that the combination of smoking and asbestos exposure is particularly hazardous. People who work with asbestos in jobs (such as shipbuilding, asbestos mining, insulation, or automotive brake repair) and smoke have a higher health risk of developing lung cancer. Using protective breathing equipment reduces this health risk.
Radon. This is an invisible, odorless gas naturally released by some soil and rocks. Exposure to radon has been associated with an increased health risk of some types of cancer, including lung cancer. Most hardware stores have kits that test home radon levels, and basements can be ventilated to reduce radon exposure.
There are no tests recommended for screening the general population for lung cancer. Doctors still need to prove that screening everyone at risk for lung cancer reduces rates of death from lung cancer in the general population. A new test, called a low-dose helical (or spiral) computed tomography (CT or CAT) scan, is currently being studied for this purpose. A CT scan creates a three-dimensional picture of the inside of the body with an x-ray machine. A computer then combines these images into a detailed, cross-sectional view that shows any abnormalities or tumors. Sometimes, a contrast medium (a special dye) is injected into a patient’s vein to provide better detail.
Health: Symptoms of Lung Cancer (Lungs)
People with lung cancer may experience the following symptoms. Sometimes people with lung cancer do not show any of these symptoms. Or, these symptoms may be caused by a health condition that is not cancer. If you are concerned about a symptom on this list, please talk with your doctor.
For people with lung cancer who have no symptoms, their lung cancer may be discovered on a chest x-ray or CT scan performed for some other reason, such as checking for heart disease. Most people with lung cancer are diagnosed when the tumor grows, takes up space, or begins to interfere with nearby structures. A lung tumor may also make fluid that can collect in the lung or the space around the lung. A tumor can push the air out of the lungs and cause the lung to collapse. In this way, a lung tumor can prevent the exchange of oxygen and carbon dioxide by blocking the flow of air into the lungs, or by using up the space normally required for oxygen to come in and carbon dioxide to go out of the lung.
Symptoms of lung cancer may include:
- Fatigue
- Cough
- Shortness of breath
- Chest pain, if a tumor invades a structure within the chest or involves the lining of the lung
- Loss of appetite
- Coughing up phlegm or mucus
- Hemoptysis (coughing up blood)
Although lung cancer can metastasize (spread) anywhere in the body, the most common sites of spread are the lymph nodes, lungs, bones, brain, liver, and structures near the kidneys called the adrenal glands. Metastases (spread to more than one area) from lung cancer can cause further breathing difficulties, bone pain, abdominal or back pain, headache, weakness, seizures, and/or speech difficulties. Rarely, a lung tumor can release hormones that result in chemical imbalances, such as low blood sodium levels or high blood calcium levels.
Symptoms such as fatigue, malaise (feeling out-of-sorts or unwell), and loss of appetite are not necessarily due to metastases. The presence of cancer anywhere in the body can cause a person to feel unwell in a general way. Loss of appetite can result in weight loss. Fatigue and weakness can further worsen breathing difficulties.
_______________________________________________________________________________________________________
_______________________________________________________________________________________________________
Lung cancer affects more than 200,000 Americans each year. Although cigarette smoking is the main cause, anyone can develop lung cancer. Lung cancer is always treatable, no matter the size, location, or if the cancer has spread.
The lungs absorb oxygen from the air and bring the oxygen into the bloodstream for delivery to the rest of the body. As the body’s cells use oxygen, they release carbon dioxide. The bloodstream carries carbon dioxide back to the lungs, and the carbon dioxide leaves the body when people exhale. The lungs contain many different types of cells. Most cells in the lung are epithelial cells. Epithelial cells line the airways and produce mucus, which lubricates and protects the lung. The lung also contains nerve cells, hormone-producing cells, blood cells, and structural or supporting cells.
There are two major types of lung cancer: non-small cell and small cell. Non-small cell lung cancer (NSCLC) arises from epithelial cells and is the most common type. Small cell lung cancer begins in the nerve cells or hormone-producing cells of the lung. The term “small cell” refers to the size and shape of the cancer cells as seen under a microscope. It is important for doctors to distinguish NSCLC from small cell lung cancer because the two types of cancer are usually treated in different ways.
Lung cancer begins when cells in the lung grow out of control and form a lump (also called a tumor, mass, lesion, or nodule). A tumor can be benign (noncancerous) or malignant (cancerous). A cancerous tumor is a collection of a large number of cancer cells that have the ability to spread to other parts of the body. A lung tumor can begin anywhere in the lung.
Once a cancerous lung tumor begins to grow, it may or may not shed cancer cells. These cells can be carried away in blood or float away in the natural fluid, called lymph, which surrounds lung tissue. Lymph flows through tubes called lymphatic vessels that drain into collecting stations called lymph nodes, the tiny, bean-shaped organs that help fight infection. Lymph nodes are located in the lungs, the center of the chest, and elsewhere in the body. The natural flow of lymph out of the lungs is toward the center of the chest, which explains why lung cancer often spreads there. When a cancer cell leaves its site of origin and moves into a lymph node or to a far away part of the body through the bloodstream, it is called metastasis.
The location and size of the initial lung tumor, and whether it has spread to lymph nodes or more distant sites, determines the stage of lung cancer. The type of lung cancer (NSCLC versus small cell) and stage of the disease (discussed later in Staging) determine what type of treatment is needed.
Statistics
In 2008, an estimated 215,020 adults (114,690 men and 100,330 women) in the United States will be diagnosed with lung cancer. Lung cancer is the second most common cancer in both men and women, and it is the leading cause of cancer deaths for both men and women. It is estimated that 161,840 deaths (90,810 men and 71,030 women) from this disease will occur this year. For all people with lung cancer, the one-year survival rate (percentage of people who survive at least one year after the cancer is detected excluding those who die from other diseases) of people is 41%. The five-year relative survival rate is 15%.
Lung cancer represents 15% of all cancer diagnoses and 29% of all cancer deaths. For men, death rates have declined consistently since 1991 at a rate of nearly 2% each year. Death rates for women with lung cancer are now slowing after increasing for decades. For unclear reasons, black men have the highest incidence and the lowest survival rates of lung cancer.
These statistics should not be taken as a death sentence. It is important to remember that statistics do not apply to an individual patient. No doctor can tell a patient how long he or she will live with lung cancer. Some patients who are told that their lung cancer will be cured do not live as long as patients who are told that their lung cancer is not curable. The important thing to remember is that lung cancer is treatable at any stage, and that these treatments have been proven to help people live longer and better, despite a diagnosis of lung cancer.
Cancer survival statistics should be interpreted with caution. These estimates are based on data from thousands of cases of this type of cancer in the United States each year, but the actual risk for a particular individual may differ. Because the survival statistics are measured in five-year (or sometimes one-year) intervals, they may not represent advances made in the treatment or diagnosis of this cancer.
Statistics adapted from the American Cancer Society's publication, Cancer Facts & Figures 2008.
To learn about the cancer terms used in this section, read the Cancer.Net Feature: Cancer Terms to Know: Basic Oncology Terms.
|
Last Updated: December 14, 2007
A risk factor is anything that increases a person’s chance of developing cancer. Some risk factors can be controlled, such as smoking, and some cannot be controlled, such as age and family history. Although risk factors can influence the development of cancer, most do not directly cause cancer. Some people with several risk factors never develop cancer, while others with no known risk factors do. However, knowing your risk factors and communicating them to your doctor may help you make more informed lifestyle and health care choices.
The following factors may raise a person’s risk of developing lung cancer:
Tobacco. Most lung cancer occurs in people who smoke. Tobacco smoke damages cells in the lungs, causing the cells to grow abnormally. The risk that smoking will lead to cancer is higher for people who smoke heavily and/or for a long time. Regular exposure to smoke from someone else’s cigarettes, cigars, or pipes (called environmental or “secondhand” tobacco smoke) can increase a person’s risk of lung cancer even if that person does not smoke.
Asbestos. These are hair-like crystals found in many types of rock and are often used as fireproof insulation in buildings. When asbestos fibers are inhaled, they can irritate the lung. Many studies show that the combination of smoking and asbestos exposure is particularly hazardous. People who work with asbestos in jobs (such as shipbuilding, asbestos mining, insulation, or automotive brake repair) and smoke have a higher risk of developing lung cancer. Using protective breathing equipment reduces this risk.
Radon. This is an invisible, odorless gas naturally released by some soil and rocks. Exposure to radon has been associated with an increased risk of some types of cancer, including lung cancer. Most hardware stores have kits that test home radon levels, and basements can be ventilated to reduce radon exposure.
The most important way to prevent lung cancer is to avoid tobacco smoke. People who never smoke have the lowest risk of lung cancer. People who smoke can reduce their risk of lung cancer by stopping smoking, but their risk of lung cancer will still be higher than people who never smoked. Attempts to prevent lung cancer with vitamins or other treatments have not worked. Beta-carotene, a drug related to vitamin A, has been tested for the prevention of lung cancer. It did not reduce the risk of cancer. In people who continued to smoke, beta-carotene actually increased the risk of lung cancer.
Screening
There are no tests recommended for screening the general population for lung cancer. Doctors still need to prove that screening everyone at risk for lung cancer reduces rates of death from lung cancer in the general population. A new test, called a low-dose helical (or spiral) computed tomography (CT or CAT) scan, is currently being studied for this purpose. A CT scan creates a three-dimensional picture of the inside of the body with an x-ray machine. A computer then combines these images into a detailed, cross-sectional view that shows any abnormalities or tumors. Sometimes, a contrast medium (a special dye) is injected into a patient’s vein to provide better detail.
|
Last Updated: December 14, 2007
People with lung cancer may experience the following symptoms. Sometimes people with lung cancer do not show any of these symptoms. Or, these symptoms may be caused by a medical condition that is not cancer. If you are concerned about a symptom on this list, please talk with your doctor.
For people with lung cancer who have no symptoms, their lung cancer may be discovered on a chest x-ray or CT scan performed for some other reason, such as checking for heart disease. Most people with lung cancer are diagnosed when the tumor grows, takes up space, or begins to interfere with nearby structures. A lung tumor may also make fluid that can collect in the lung or the space around the lung. A tumor can push the air out of the lungs and cause the lung to collapse. In this way, a lung tumor can prevent the exchange of oxygen and carbon dioxide by blocking the flow of air into the lungs, or by using up the space normally required for oxygen to come in and carbon dioxide to go out of the lung.
Symptoms of lung cancer may include:
- Fatigue
- Cough
- Shortness of breath
- Chest pain, if a tumor invades a structure within the chest or involves the lining of the lung
- Loss of appetite
- Coughing up phlegm or mucus
- Hemoptysis (coughing up blood)
Although lung cancer can metastasize (spread) anywhere in the body, the most common sites of spread are the lymph nodes, lungs, bones, brain, liver, and structures near the kidneys called the adrenal glands. Metastases (spread to more than one area) from lung cancer can cause further breathing difficulties, bone pain, abdominal or back pain, headache, weakness, seizures, and/or speech difficulties. Rarely, a lung tumor can release hormones that result in chemical imbalances, such as low blood sodium levels or high blood calcium levels.
Symptoms such as fatigue, malaise (feeling out-of-sorts or unwell), and loss of appetite are not necessarily due to metastases. The presence of cancer anywhere in the body can cause a person to feel unwell in a general way. Loss of appetite can result in weight loss. Fatigue and weakness can further worsen breathing difficulties.
|
Last Updated: December 14, 2007
Doctors use many tests to diagnose cancer and determine if it has spread from the lung. Some tests may also determine which treatment may be the most effective. For most types of cancer, a biopsy is the only way to make a definitive diagnosis of cancer. If a biopsy is not possible or more information is needed, the doctor may suggest other tests that will help make a diagnosis. Imaging tests may be used to find out whether the cancer has metastasized, but they can never be used to diagnose lung cancer. Only a biopsy can do that. Your doctor may consider these factors when choosing a diagnostic test:
- Location of the suspected cancer
- Size of the suspected cancer
- Age and health condition
- The type of cancer suspected
- Severity of symptoms
- Previous test results
In addition to a physical examination, the following tests may be used to diagnose lung cancer:
Biopsy. A biopsy is the only way to make a diagnosis of lung cancer. A biopsy is the removal of a small amount of tissue for examination under a microscope. The sample removed from the biopsy is analyzed by a pathologist (a doctor who specializes in interpreting laboratory tests and evaluating cells, tissues, and organs to diagnose disease). If cancer cells are present, the pathologist will determine if it is small cell lung cancer or NSCLC, based on its appearance under the microscope.
Common procedures doctors use to obtain tissue for the diagnosis and staging of lung cancer are listed below:
Sputum cytology. If there is reason to suspect lung cancer, the doctor may ask a person to cough up some phlegm so it can be examined under the microscope. A pathologist can find cancer cells mixed in with the mucus.
Bronchoscopy. In this procedure, the doctor passes a thin, flexible tube with a light on the end into the mouth or nose, down through the main windpipe, and into the breathing passages of the lungs. A surgeon or a pulmonologist (a medical doctor who specializes in the diagnosis and treatment of lung disease) may perform this procedure. The tube lets the doctor see inside the lung. Tiny tools inside the tube can take samples of fluid or tissue, so the pathologist can examine them. Patients are given mild anesthesia (medication to put them to sleep) during a bronchoscopy.
Needle aspiration. After numbing the skin, a special type of radiologist, called an interventional radiologist, inserts a small needle through the chest and directly into the lung tumor. The doctor uses the needle to aspirate (suck out) a small sample of tissue for testing. Often, the radiologist uses a chest CT scan or special x-ray machine called a fluoroscope to guide the needle.
Bone marrow biopsy. For patients with small cell lung cancer, doctors sometimes use a local anesthetic (to numb the area) and a special needle to remove a tiny piece of bone (typically from the hip bone) in order to determine whether small cell cancer is present within the bones.
Thoracentesis. After numbing the area, a needle is inserted through the chest wall and into the space between the lung and the wall of the chest where fluid can collect. The fluid is removed and checked for cancer cells by the pathologist.
Thoracotomy. This procedure is performed in an operating room with the help of general anesthesia. A surgeon then makes an incision in the chest, examines the lung directly, and takes tissue samples for testing. A thoracotomy is the procedure surgeons most often perform to completely remove a lung tumor.
Thoracoscopy. Through a small cut in the skin of the chest wall, a surgeon can insert a special instrument and a small video camera to assist in the examination of the inside of the chest. Patients require general anesthesia, but recovery time may be shorter given the smaller incisions. This procedure may be referred to as “VATS” (video-assisted thoracoscopic surgery).
Mediastinoscopy. A surgeon examines and takes a sample of the lymph glands in the center of the chest (underneath the breastbone) by making a small incision at the top of the breastbone. This procedure also requires general anesthesia and is done in an operating room.
Imaging tests
In addition to biopsies and surgical procedures, imaging scans are vital to the care of people with lung cancer. However, no test is perfect, and no scan can diagnose lung cancer. Only a biopsy can do that. Chest x-ray and scan results must be combined with a person’s medical history, a physical examination, blood tests, and biopsy information to form a complete story about where the cancer began and whether or where it has spread.
CT scan. This test produces images that allow doctors to see the size and location of lung tumors and/or lung cancer metastases.
Magnetic resonance imaging (MRI) scan. This test also produces images that allow doctors to see the size and location of lung tumors and/or lung cancer metastases. An MRI uses magnetic fields, not x-rays, to produce detailed images of the body. A contrast medium (a special dye) may be injected into a patient’s vein to provide better detail. MRI scanning is imprecise when used to image a structure that is moving, like your lungs, which move with each breath a person takes. For that reason, the MRI scan is rarely used to study the lungs themselves.
Scans are also available that use radioactive molecules, called tracers, injected into the blood to show where cancer is possibly located:
Positron emission tomography (PET) scan. A PET scan is a way to create pictures of organs and tissues inside the body. A small amount of a radioactive substance is injected into a patient’s body and absorbed by the organs or tissues being studied. This substance gives off energy that is detected by a scanner, which produces the images. A specialist in nuclear medicine helps your doctor interpret PET scans.
Bone scan. A bone scan uses a radioactive tracer to look at the inside of the bones. The tracer is injected into a patient’s vein. It collects in areas of the bone and is detected by a special camera. Healthy bone appears gray to the camera, and areas of injury, such as those caused by cancer, appear dark.
Bone scans and PET scans are often used in combination with information gathered from a CT scan, MRI, regular x-rays, and a physical examination.
Finding out where the cancer started
Lung cancer starts in the lung. Many other types of cancer start elsewhere in the body and spread to the lungs when they metastasize. For example, breast cancer that has spread to the lungs is still called breast cancer. Therefore, it is important for doctors to know if cancer started in the lung or elsewhere.
To find where the cancer started, the doctor takes into account the patient’s symptoms and medical history, physical examination, the appearance of the tumor on x-rays and scans, and risk factors for cancer. A pathologist can perform tests on the biopsy sample to help identify the origin of a cancer, and the doctor may order other tests for the patient to rule out specific types of cancer. If, after these considerations, the doctor is still not sure where the cancer started, the doctor may give a diagnosis of metastatic cancer “of unknown primary.” Most treatment for metastatic cancer of unknown primary that are first discovered in the chest are the same as those for metastatic lung cancer.
Prognosis
The stage of lung cancer influences prognosis. While lung cancer is treatable at any stage, only certain stages of lung cancer can be cured. Some characteristics of patients are important to prognosis, regardless of whether the goal is treatment or cure.
Doctors measure a patient’s general strength and vigor using an index known as performance status. Patients who are strong enough to go about their daily activities without assistance and even work outside the home can safely receive chemotherapy, radiation therapy, and/or surgery. Treatment may not be as effective for patients with bone or liver metastases from lung cancer, excessive weight loss, ongoing cigarette use, or pre-existing medical conditions such as heart disease or emphysema.
It is important to note that a patient’s age has never been useful in predicting whether that patient will benefit from treatment. The average age of patients with lung cancer in the United States is 71. A patient’s age should never be used as the only reason for deciding on what treatment is best, especially for older patients who are otherwise physically fit and have no other health problems besides lung cancer.
Staging of Lung Cancer
Staging is a way of describing a cancer, such as where it is located, if or where it has spread, and if it is affecting the functions of other organs in the body. Doctors use diagnostic tests to determine the cancer’s stage, so staging may not be complete until all of the tests are finished. Knowing the stage helps the doctor to decide what kind of treatment is best and can help predict a patient’s prognosis (chance of recovery). There are different stage descriptions for different types of cancer.
As doctors learn new information about lung cancer, the staging
system may be updated or changed. The International Association for the
Study of Lung Cancer (IASLC) is expected to issue updated staging
information in 2009, and these changes may mean that more patients
could be recommended for adjuvant chemotherapy (chemotherapy after
surgery).
In general, a lower number stage of lung cancer is associated with a better outcome. However, no doctor can predict how long a patient will live with lung cancer based only on the stage of disease, because lung cancer is different in each person, and individuals respond to treatment differently.
Staging is different for NSCLC and small cell lung cancer. Each staging system is described below.
Staging of NSCLC
The stage of NSCLC is described by a number, one through four (Roman numerals I through IV). One way to determine the staging of NSCLC is to determine whether the cancer can be completely removed by a surgeon. To completely remove the lung cancer, the surgeon must remove the cancer along with the surrounding, normal lung tissue.
Stage I and II
In general, NSCLC that is stage one (I) or two (II) has a size and location that makes it possible for a surgeon to completely remove it. Stage I cancer has not spread to any lymph nodes. Stage II cancer may involve lymph nodes, but the lymph nodes are contained within the surrounding lung, so they may be removed along with the section of lung where the cancer started.
Stage III
Stage three (III) NSCLC is difficult, and sometimes impossible, to remove. For example, lung cancer may spread to the lymph nodes located in the center of the chest, which is outside the lung. In this situation, it is less likely that the surgeon can completely remove the cancer because removal of the cancer has to be performed bit by bit.
When the cancer has spread to lymph nodes in the center of the chest, on the same side as where the cancer started, it is known as stage three-A (IIIA). When the cancer spreads to lymph nodes on the opposite side of the chest, it is known as stage three-B (IIIB). In general, surgery is not successful for any stage IIIB or IV lung cancer. Other situations that make a lung cancer impossible to remove are if it has spread to the lymph nodes above the collarbone or into the fluid surrounding the lung, or if the cancer grows into vital structures within the chest, such as the heart, large blood vessels or the main breathing tubes leading to the lungs; all of these conditions are considered stage IIIB.
Stage IV
Stage four (IV) means NSCLC has spread to different sections (lobes) of the lung, or to distant sites within the body by way of the bloodstream. Once released in the blood, NSCLC can spread anywhere in the body, but has a tendency to spread to the brain, bones, liver, and to the adrenal glands.
Staging of small cell lung cancer
Because almost all small cell lung cancer has spread outside the lung when discovered, very few patients with small cell lung cancer are treated with surgery, and all receive chemotherapy. Some patients with small cell lung cancer can benefit from radiation therapy. The staging for small cell lung cancer helps identify which patients can be treated with radiation therapy in addition to chemotherapy.
Small cell lung cancer is classified as either limited stage or extensive stage:
- Limited stage means the cancer is located on one side of the chest
and involves a single region of the lung and adjacent lymph nodes. This
region can be treated in its entirety with radiation therapy. About 30%
of patients have limited stage.
- Extensive stage means the cancer has spread to other regions of the chest, or outside of the chest, and cannot be treated completely with radiation therapy. Most patients (70%) have extensive stage disease and are treated with chemotherapy only.
_____________________________________________________________________________________________
Natural Alternative Treatment Options: CANCER FREE
_______________________________________________________________________________________________________
Health: Conventional Treatment of Lung Cancer (Lungs)
Treatment
The treatment of lung cancer depends on the size and location of the tumor, whether the cancer has spread, and the person’s overall health. In many cases, a team of doctors will work with the patient to determine the best treatment plan.
This section outlines treatments that are the standard of care (the best treatments available) for this specific type of cancer. Patients are also encouraged to consider clinical trials when making treatment plan decisions. A clinical trial is a research study to test a new treatment to prove it is safe, effective, and possibly better than standard treatment. Your doctor can help you review all treatment options.
There are four basic ways to treat lung cancer: surgery, radiation therapy, chemotherapy, and targeted therapy. Each treatment option is described below, followed by an outline of treatment by the type and stage of cancer.
Surgery
A thoracic surgeon is specially trained to perform lung cancer surgery. The goal of surgery is the complete removal of the lung tumor and the nearby lymph nodes in the chest. The tumor must be removed with a surrounding border of normal lung tissue (called the margin). A “negative margin” means that when the pathologist examines the lung, or piece of lung that has been removed by the surgeon, no traces of cancer were found in the healthy tissue surrounding the tumor.
The lungs have five lobes, three in the right lung and two in the left lung. For NSCLC, a lobectomy (removal of an entire lobe of the lung) has been shown to be the most effective type of surgery, even when the lung tumor is very small. If, for whatever reason, the surgeon cannot remove an entire lobe of the lung, the surgeon can remove the tumor in a procedure called a wedge, surrounded by a margin of normal lung. If the tumor is close to the center of the chest, the surgeon may have to perform a pneumonectomy (surgery to remove the entire lung). The time it takes to recover from lung surgery depends on how much of the lung is removed and the health of the patient before surgery.
Adjuvant therapy
Adjuvant therapy is treatment that is given after surgery to lower the risk of the lung cancer returning. Adjuvant therapy includes radiation therapy, chemotherapy, and targeted therapy. It is intended to eliminate any lung cancer cells that may be lingering in the body. Adjuvant therapy may decrease the risk of recurrence, but does not necessarily eliminate it.
Along with staging, other sophisticated tools can help determine prognosis and help you and your doctor make decisions about whether adjuvant therapy would be helpful in your treatment. The website Adjuvant! Online (www.adjuvantonline.com) is one such tool that your doctor can access to interpret a variety of factors that are important for making the treatment decision. This website should only be used with the interpretation of your doctor.
Radiation therapy is the use of high energy x-rays or other particles to kill cancer cells. If you need radiation therapy, you will be asked to see a specialist called a radiation oncologist. Like surgery, radiation therapy cannot be used to treat widespread cancer. Radiation only kills cancer cells directly in the path of the radiation beam. It also damages the normal cells caught in its path, and for this reason, it cannot be used to treat large areas of the body. Patients with lung cancer treated with radiation therapy often experience fatigue and loss of appetite. If radiation therapy is given to the neck, or center of the chest, patients may also develop a sore throat and have difficulty swallowing. Skin irritation, like sunburn, may occur at the treatment site. Most side effects go away soon after treatment is finished.
If the radiation therapy irritates or inflames the lung, patients may develop a cough, fever, or shortness of breath months and sometimes years after the radiation therapy ends. This condition occurs in about 15% of patients and is called radiation pneumonitis. If it is mild, radiation pneumonitis does not require treatment and resolves on its own. If it is severe, radiation pneumonitis may require treatment with steroid medications, such as prednisone. Radiation therapy may also cause permanent scarring of the lung tissue near the site of the original tumor. Typically, the scarring does not lead to symptoms. Widespread scarring can lead to permanent cough and shortness of breath. For this reason, radiation oncologists carefully plan the treatments using CT scans of the chest to minimize the amount of normal lung tissue exposed to the radiation beam.
Chemotherapy is the use of drugs to kill cancer cells. Systemic chemotherapy is delivered through the bloodstream, targeting cancer cells throughout the body. Chemotherapy is given by a medical oncologist. Most chemotherapy used for lung cancer is injected into a vein (called intravenous, or IV injection).
The side effects of chemotherapy depend on the individual and the dose used, but can include fatigue, risk of infection, nausea and vomiting, loss of appetite, and diarrhea. Nausea and vomiting are often avoidable. These side effects usually go away once treatment is finished.
Chemotherapy may also damage normal cells in the body, including blood cells, skin cells, and nerve cells. This may result in low blood counts, an increased risk of infection, hair loss, mouth sores, and/or numbness or tingling in the hands and feet. Your medical oncologist can often prescribe drugs to help provide relief from many side effects. Hormone injections are also used to prevent white and red blood cell counts from becoming too low.
Newer chemotherapy treatment plans cause fewer side effects and are as effective as older treatments. Chemotherapy has been shown to improve both the length and quality of life in people with lung cancer of all stages.
The medications used to treat cancer are continually being evaluated. Talking with your doctor is often the best way to learn about the medications prescribed for you, their purpose, and their potential side effects or interactions with other medications.
Targeted therapy
Targeted therapy is a treatment that target faulty genes or proteins that contribute to cancer growth and development. These abnormal proteins are present in unusually large amounts in certain lung cancer cells.
A monoclonal antibody is a drug made in the laboratory that blocks a receptor on the cell surface, which is like the doorway of the cell. Bevacizumab (Avastin) is a monoclonal antibody given in combination with chemotherapy for lung cancer. Drugs like bevacizumab block the formation of new blood vessels (also called angiogenesis), which is necessary for a tumor to grow and spread. The health risk of serious bleeding for patients taking bevacizumab is about 2%.
Erlotinib (Tarceva) is a drug approved by the U.S. Food and Drug Administration (FDA) for locally advanced and metastatic NSCLC. It blocks the epidermal growth factor receptor (EGFR), a protein that helps lung cancer cells grow and multiply. This medication is a pill that can be taken by mouth. The side effects of erlotinib include rash that looks like acne and diarrhea.
Many doctors recommend treatment with cetuximab (Erbitux), a monoclonal antibody that targets and blocks the EGFR. This is drug is given along with chemotherapy to treat lung cancer, especially when treatment with bevacizumab is unsafe. The side effects of cetuximab include rash and allergic reactions.
Gefitinib (Iressa) is another drug that works like erlotinib. It is available only to people who were already taking it, had taken it in the past and had a good effect, or as part of a clinical trial.
Combining treatments
Most patients with lung cancer are treated by more than one specialist with more than one type of treatment. For example, chemotherapy can be prescribed before or after surgery, or before, during, or after radiation therapy. Patients should have a sense that their doctors have a coordinated plan of care and are communicating effectively with one another. If patients do not feel that the surgeon, radiation oncologist, or medical oncologist is communicating effectively with them or each other about the goals of treatment and the plan of care, patients should discuss this with their doctors or seek additional opinions before treatment.
Controlling physical symptoms caused by lung cancer
Chemotherapy is not as effective as radiation therapy or surgery to treat lung cancer that has spread to the brain. For this reason, lung cancer that has spread to the brain is treated instead with radiation therapy, surgery, or both. Most patients with brain metastases from lung cancer are treated with radiation therapy to the entire brain. This can cause side effects such as hair loss, fatigue, and redness of the scalp. With a small tumor, a type of radiation therapy called stereotactic radiosurgery can focus radiation only on the tumor in the brain and minimize side effects.
Radiation therapy or surgery may also be used to treat metastases that are causing pain or other symptoms.
- A tumor in the chest that is bleeding or blocking the lung passages can be shrunk by radiation therapy.
- During a bronchoscopy lung passages blocked by cancer can be opened to improve breathing.
- A surgeon can use a laser to burn away a tumor or place a mechanical stent (support) to prop open an airway passage.
- Bone metastases that weaken important bones can be treated with surgery and reinforced using metal implants. Bone metastases can also be treated with radiation therapy.
Medications can also help treat the symptoms of lung cancer.
- Medications are used to treat cancer pain. Most hospitals and
cancer centers have pain control specialists that design pain-relief
treatments even for very severe cancer pain. Many drugs used to treat
cancer pain, especially morphine, can also relieve shortness of breath
caused by cancer.
- Medications can be used to suppress cough, open closed airways, or reduce bronchial secretions.
- Prednisone or methylprednisolone (multiple brand names) can reduce
inflammation caused by lung cancer or radiation therapy and improve
breathing.
- Extra oxygen from small, portable tanks can help make up for the lung’s reduced ability to extract oxygen from the air.
- Medications called bisphosphonates strengthen bones, lessen bone pain, and can help prevent future bone metastases.
- Appetite stimulants and nutritional supplements can improve appetite and lessen weight loss.
Health: Prevention of Lung Cancer (Lungs)
The most important way to prevent lung cancer is to avoid tobacco
smoke. People who never smoke have the lowest health risk of lung cancer.
People who smoke can reduce their risk of lung cancer by stopping
smoking, but their risk of lung cancer will still be higher than people
who never smoked. Attempts to prevent lung cancer with vitamins or
other treatments have not worked. Beta-carotene, a drug related to
vitamin A, has been tested for the prevention of lung cancer. It did
not reduce the risk of cancer. In people who continued to smoke,
beta-carotene actually increased the risk of lung cancer.
Even after lung cancer is diagnosed, it is
still not too late to benefit from stopping cigarette smoking. People
who stop smoking have an easier time with all treatments, feel better,
live longer, and have a lower risk of developing a second lung cancer.
Stopping smoking is never easy and even harder when facing the
diagnosis of lung cancer and treatment. People who smoke should seek
help from family, friends, smoking cessation programs, and health care
professionals. None of the smoking cessation aids available interfere
with cancer treatment.
_______________________________________________________________________________________________________
Disclaimer: This information is not presented by a medical practitioner. Therefore any content of this site is strictly intended for educational and informational purpose only. Any access to this site is strictly on a voluntary basis and at the sole discretion of the user. No content of this site is intended as a substitute for medical advice, diagnosis or treatment, nor constitute the practice of any medical profession or health care provider. The information provided on this site is here to educate visitors on health issues that may affect their lives. Otherwise, always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition. And never disregard professional medical advice or delay in seeking it because of something you have read.
Sources: NIH News In Health/National Institutes of Health/National Library of Medicine/Dept of Health and Human Services <<Previous (Home Page) Next>>
